PLTR vs TEM: AI Stock Comparison

Palantir Technologies Inc. vs Tempus AI, Inc.: AI exposure, key metrics, next earnings dates, upcoming catalysts and risks — every number linked to its source.

$PLTR scores higher on AI exposure (5/5 vs 4/5) under our published rubric. The score measures how directly each business is tied to AI, not which stock to buy.
⏱ Next catalyst: Not enough tracked catalysts to compare.
$PLTR 🏆
Palantir Technologies Inc.
Data and AI platforms for government and enterprise.
$TEM
Tempus AI, Inc.
AI-powered precision-medicine diagnostics and data.
AI exposure score⚡⚡⚡⚡⚡ 5/5⚡⚡⚡⚡⚡ 4/5
Shares outstandingNot shown (multiple share classes or no recent cover-page figure)Not shown (multiple share classes or no recent cover-page figure)
CategoryAI softwareAI software
Key metrics
Revenue (latest quarter) $2.31B
10-Q period ended 2026-09-30; +96% y/y · SEC filing
Gross margin 83.4%
Gross profit / revenue, same quarter · SEC filing
Operating income $1.08B
Same quarter; 47% operating margin · SEC filing
Revenue (latest quarter) $411.5M
10-Q period ended 2026-09-30; +23% y/y · SEC filing
Operating income -$56.9M
Same quarter; -14% operating margin · SEC filing
Net income -$14.9M
Same quarter · SEC filing
Next earningsNot yet announced / not on our calendarNot yet announced / not on our calendar
Next catalystNot yet announced / not on our calendarNot yet announced / not on our calendar
Upcoming catalystsNone trackedNone tracked
Most recent reported
Nov 2, 2026
Palantir Technologies Inc. reports quarterly results · source
Bellwether for enterprise/government AI software demand. Revenue: $2.31B (+96% y/y), per 10-Q.
Nov 2, 2026
Tempus AI, Inc. reports quarterly results · source
AI-driven diagnostics; a pure-play AI healthcare name. Revenue: $411.5M (+23% y/y), per 10-Q.
Key risks
  • “Failure to comply with laws, regulations, or contractual provisions applicable to our business could cause us to lose government customers or our ability to contract with the U.S. and other…” — 10-K risk factor (filed 2026-02-17) · source
  • “Variable rate indebtedness that we may incur under our credit facility will subject us to interest rate risk, which could cause our debt service obligations to increase significantly.” — 10-K risk factor (filed 2026-02-17) · source
  • “We have incurred significant losses since inception, we may continue to incur losses in the future, and we may not be able to generate sufficient revenue to achieve and maintain…” — 10-K risk factor (filed 2026-02-24) · source
  • “If we cannot compete successfully with our competitors, we may be unable to increase or sustain our revenue or to achieve and then sustain profitability.” — 10-K risk factor (filed 2026-02-24) · source
AI angle

Palantir's AIP platform puts large language models to work on customers' own data. U.S. government and commercial demand for AI deployments drive its growth.

Tempus combines genomic testing with a large clinical data set and AI models for diagnostics and drug development.

Full analysis: $PLTR →Full analysis: $TEM →

The morning brief

Today's AI-stock catalysts in your inbox before the open. Free, 2-minute read.

Related matchups

Deep dives: PLTR next earnings & catalysts · TEM next earnings & catalysts · AI earnings this week